1. Examine the risk of incident of MCI, dementia and specifically Alzheimer’s dementia associated with proton pump inhibitors

2. Assess if PPI use confers a higher risk of dementia or AD in persons with MCI at baseline compared to normal cognition at baseline

Session date: 
11/02/2017 - 8:00am to 9:00am CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Chandni Patel, MD